3341 The RegiSONIC Disease Registry Study: Safety and effectiveness of vismodegib or surgery as primary treatment in patients with locally advanced basal cell carcinoma

Author(s):

M. Lacouture ◽

J. Guillen ◽

R. Kudchadkar ◽

G. Rogers ◽

T. Olencki ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Primary Treatment ◽

Registry Study ◽

Disease Registry ◽

The RegiSONIC Disease Registry Study: Treatment of vismodegib-related adverse events (AEs) in patients with locally advanced basal cell carcinoma

10.1016/j.jaad.2015.02.786 ◽

2015 ◽

Vol 72 (5) ◽

pp. AB193

Keyword(s):

Basal Cell Carcinoma ◽

Adverse Events ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Registry Study ◽

Disease Registry ◽

Preliminary effectiveness and safety in the first 88 patients with newly diagnosed locally advanced basal cell carcinoma treated with vismodegib in the RegiSONIC Disease Registry study

10.1016/j.jaad.2016.02.794 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB202

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Newly Diagnosed ◽

Registry Study ◽

Disease Registry ◽

3332 Real-world treatment of vismodegib (VISMO)-related adverse events (AEs) in patients with locally advanced basal cell carcinoma: Report from the RegiSONIC Disease Registry Study

European Journal of Cancer ◽

10.1016/s0959-8049(16)31850-0 ◽

2015 ◽

Vol 51 ◽

pp. S675 ◽

Cited By ~ 2

Author(s):

M. Lacouture ◽

J. Guillen ◽

R. Kudchadkar ◽

G. Rogers ◽

T. Olencki ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Adverse Events ◽

Cell Carcinoma ◽

Basal Cell ◽

Real World ◽

Locally Advanced ◽

Registry Study ◽

Disease Registry ◽

Management of common vismodegib (VISMO)-related adverse events in patients with locally advanced basal cell carcinoma (laBCC): RegiSONIC Disease Registry Study

10.1016/j.jaad.2016.02.786 ◽

2016 ◽

Vol 74 (5) ◽

pp. AB200 ◽

Keyword(s):

Basal Cell Carcinoma ◽

Adverse Events ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Registry Study ◽

Disease Registry ◽

Determination of locally advanced basal cell carcinoma (BCC) in the first 285 patients enrolled in the RegiSONIC disease registry study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.9022 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 9022-9022

Author(s):

Simon S. Yoo ◽

Jean Y. Tang ◽

Gary S. Rogers ◽

Thomas Olencki ◽

Mario E. Lacouture ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Registry Study ◽

Disease Registry ◽

The RegiSONIC disease registry: Preliminary effectiveness and safety in the first 66 newly diagnosed locally advanced basal cell carcinoma (BCC) patients treated with vismodegib.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.9023 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 9023-9023 ◽

Author(s):

Mario E. Lacouture ◽

Jean Y. Tang ◽

Gary S. Rogers ◽

Thomas Olencki ◽

Ragini Reiney Kudchadkar ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Newly Diagnosed ◽

Disease Registry ◽

Neoadjuvant Vismodegib followed by radiation in locally advanced basal cell carcinoma

Current Problems in Cancer ◽

10.1016/j.currproblcancer.2021.100736 ◽

2021 ◽

pp. 100736

Author(s):

Diya M Sabu ◽

Jeska Kroes ◽

Charles Gilham ◽

Ann Fleming ◽

Fergal C Kelleher

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

LBA47 Primary analysis of phase II results for cemiplimab in patients (pts) with locally advanced basal cell carcinoma (laBCC) who progress on or are intolerant to hedgehog inhibitors (HHIs)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.2277 ◽

2020 ◽

Vol 31 ◽

pp. S1175-S1176 ◽

Author(s):

A.J. Stratigos ◽

A. Sekulic ◽

K. Peris ◽

O. Bechter ◽

C. Dutriaux ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Basal Cell ◽

Locally Advanced ◽

Primary Analysis ◽

26200 Tumor burden in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma following treatment with sonidegib: Results of the 42-month BOLT study

10.1016/j.jaad.2021.06.377 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB89

Author(s):

Michael Migden ◽

Aaron S. Farberg ◽

James Spencer ◽

Felix Kiecker ◽

Alexander Guminski ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Tumor Burden ◽

Metastatic Basal Cell Carcinoma ◽

16306 Effect of concomitant medications on efficacy of sonidegib 200 mg daily in patients with locally advanced basal cell carcinoma: Results of the 42-month randomized, double-blind BOLT study

10.1016/j.jaad.2020.06.324 ◽

2020 ◽

Vol 83 (6) ◽

pp. AB59

Author(s):

Reinhard Dummer ◽

Michael R. Migden ◽

Nicholas A. Squittieri ◽

Li Liu ◽

Alexander Guminski ◽

...

Keyword(s):

Basal Cell Carcinoma ◽

Cell Carcinoma ◽

Basal Cell ◽

Locally Advanced ◽

Double Blind ◽

Concomitant Medications ◽